Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won

Detalles Bibliográficos
Autores principales: Torreggiani, Massimo, Blanchi, Sophie, Fois, Antioco, Fessi, Hafedh, Piccoli, Giorgina Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055923/
https://www.ncbi.nlm.nih.gov/pubmed/33887320
http://dx.doi.org/10.1016/j.kint.2021.04.010
_version_ 1783680542061887488
author Torreggiani, Massimo
Blanchi, Sophie
Fois, Antioco
Fessi, Hafedh
Piccoli, Giorgina Barbara
author_facet Torreggiani, Massimo
Blanchi, Sophie
Fois, Antioco
Fessi, Hafedh
Piccoli, Giorgina Barbara
author_sort Torreggiani, Massimo
collection PubMed
description
format Online
Article
Text
id pubmed-8055923
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80559232021-04-20 Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won Torreggiani, Massimo Blanchi, Sophie Fois, Antioco Fessi, Hafedh Piccoli, Giorgina Barbara Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-06 2021-04-20 /pmc/articles/PMC8055923/ /pubmed/33887320 http://dx.doi.org/10.1016/j.kint.2021.04.010 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Torreggiani, Massimo
Blanchi, Sophie
Fois, Antioco
Fessi, Hafedh
Piccoli, Giorgina Barbara
Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
title Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
title_full Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
title_fullStr Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
title_full_unstemmed Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
title_short Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
title_sort neutralizing sars-cov-2 antibody response in dialysis patients after the first dose of the bnt162b2 mrna covid-19 vaccine: the war is far from being won
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055923/
https://www.ncbi.nlm.nih.gov/pubmed/33887320
http://dx.doi.org/10.1016/j.kint.2021.04.010
work_keys_str_mv AT torreggianimassimo neutralizingsarscov2antibodyresponseindialysispatientsafterthefirstdoseofthebnt162b2mrnacovid19vaccinethewarisfarfrombeingwon
AT blanchisophie neutralizingsarscov2antibodyresponseindialysispatientsafterthefirstdoseofthebnt162b2mrnacovid19vaccinethewarisfarfrombeingwon
AT foisantioco neutralizingsarscov2antibodyresponseindialysispatientsafterthefirstdoseofthebnt162b2mrnacovid19vaccinethewarisfarfrombeingwon
AT fessihafedh neutralizingsarscov2antibodyresponseindialysispatientsafterthefirstdoseofthebnt162b2mrnacovid19vaccinethewarisfarfrombeingwon
AT piccoligiorginabarbara neutralizingsarscov2antibodyresponseindialysispatientsafterthefirstdoseofthebnt162b2mrnacovid19vaccinethewarisfarfrombeingwon

Ejemplares similares